.png)
3D Tumoroid Model
Scalable organoid/Spheroid models
The 3D tumor spheroid/organoid tissue model arrays developed by Apricell and powered by the Apricell's proprietary platforms offer a more accurate and physiologically relevant model, simulating the architecture and cellular dynamics of solid tumors. Cancer biology research, high-throughput therapeutic screening, and personalized therapy development can all be conducted using these tissue model arrays, which replicate key tumor features, such as nutrient gradients and cell heterogeneity.
​
​
​
​​​​​
​​​​​
Multicellular Spheroid Array Models
Spheroids are 3D cell clusters that closely resemble real tissues or microtumors, offering a more realistic environment than traditional 2D cultures. These in vitro models, often made from cancer or other specialized cells, have become valuable tools for studying tissue behavior and disease in a setting that mimics in vivo conditions.
Human-derived Organoid Array Models
Patient-derived organoids (PDOs) are 3D miniaturized structures grown from a patient's tumor tissue, offering a personalized model for studying cancer. These organoids closely mimic the structure and behavior of real tumors, making them powerful tools for understanding disease progression and testing drug responses tailored to individual patients.
Patient-derived Xenograft Organoid Array Models
Patient-derived xenograft organoids (PDXOs) are 3D cultures created from patient tumor tissues that closely replicate the human tumor microenvironment. Easier and faster to establish than traditional PDX models, PDXOs are ideal for high-throughput drug screening and personalized cancer research, offering a cost-effective and scalable preclinical platform.